Elevated non-HDL-C linked to higher mortality in patients undergoing peritoneal dialysis: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-07-15 04:15 GMT | Update On 2021-07-15 05:55 GMT

China: An increased level of non-HDL-C raises the risk of cardiovascular (CV) mortality and all-cause mortality in patients undergoing peritoneal dialysis (PD), researchers report in a recent study in the Journal of Clinical Lipidology.

Peritoneal dialysis is a treatment for kidney failure that used the abdomen lining (called peritoneum), or, belly for filtering blood inside the body. Fengxian Huang, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China, and colleagues aimed to evaluate the association of non-HDL-C with cardiovascular and all-cause mortality in PD patients in a prospective cohort study.

The study included a total of 1,616 incident PD patients from a single PD center in South China. They were followed for a median of 47.6 months. Cox regression analysis was used to evaluate the independent association of non-HDL-C with CV and all-cause mortality.

Also Read: Peritoneal Dialysis is significantly improving patient outcomes: Experts

Upon analysis, the researchers found that:

· During the follow-up period, 31.4% patients died, of which 49.0% were due to CV events.

· Atherosclerotic CV mortality accounted for 59.8% of CV mortality.

· In multivariable models, for 1-SD increase in non-HDL-C level, the hazard ratios (HRs) for CV and all-cause mortality were 1.52 and 1.24 respectively.

· Non-HDL-C was positively associated with atherosclerotic CV mortality (HR, 1.29) but not associated with nonatherosclerotic CV mortality (HR, 0.79).

· The quartile analyses showed a similar pattern to the continuous variable analyses of non-HDL-C levels for CV and all-cause mortality but did not demonstrate statistical significance for atherosclerotic or nonatherosclerotic CV mortality.

Also Read: Higher-dose IV iron confers greater cardiovascular benefit in patients on dialysis: Study

"Our findings demonstrated that an elevated non-HDL-C level was independently associated with an increased risk of CV mortality, especially atherosclerotic CV mortality, and all-cause mortality in incident PD patients," concluded the authors.

Reference:

The study titled, "Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients," is published in the Journal of Clinical Lipidology.

DOI: https://www.lipidjournal.com/article/S1933-2874(21)00114-8/fulltext

Article Source : Journal of Clinical Lipidology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Elevated non-HDL-C linked to higher mortality in patients undergoing peritoneal dialysis: Study

Similar News

Even Mild Aldosterone Increase Linked to Hypertension and Kidney Disease Risk: Study

Prioperative Dexmedetomidine Fails to Prevent AKI After Partial Nephrectomy, suggests study

Rheumatoid Arthritis Patients Face Higher Risk of Kidney Stones: Study

Developing novel drug for acute MI, acute kidney injury, and subsequent chronic organ failure: Study

Greater Kidney Complications in Patients Diagnosed with Type 2 Diabetes Before 40: Study Finds

IV Iron Therapy Valuable Despite No Link with h-cTnT in Hemodialysis Patients: Study

Steroidal MRAs Ineffective and Risky in Kidney Transplant Recipients: Study

World's first clinical trial showing lubiprostone aids kidney function, finds study